Literature DB >> 20332463

TLR4 and NOD2/CARD15 genetic polymorphisms and their possible role in gastric carcinogenesis.

L Rigoli1, C Di Bella, F Fedele, V Procopio, M Amorini, G Lo Giudice, P Romeo, F Pugliatti, G Finocchiaro, R Lucianò, R A Caruso.   

Abstract

UNLABELLED: The aim of this study was to evaluate the role of TLR4 and NOD2/CARD15 genes in gastric carcinogenesis. PATIENTS AND METHODS: We investigated the allelic frequencies of TLR4 (D299G and T399I) and NOD2/CARD15 (R702W, G908R, and L1007finsC) SNPs in 87 asymptomatic serologically H. pylori-positive individuals (Group I), in 63 patients with antrum-predominant gastritis (Group II) and in 60 patients with corpus-predominant gastritis or pangastritis (Group III).
RESULTS: There was significant difference in allelic frequencies of TLR4 D299G SNP in Group II (p=0.02; OR 2.97) as well as in Group III (p=0.001; OR 4.80). Significant difference of T399I SNP allele frequency was only found in Group III (p=0.009; OR 3.73). The allele frequencies of NOD2/CARD15 G908R and of L1007insC SNP were higher in Group III (p=0.003, OR 5.18; p=0.03; OR 3.66, respectively).
CONCLUSION: TLR4 and NOD2/CARD15 genes are associated with high risk Group III patients and, therefore, they appear to play a role in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332463

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

Review 1.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

2.  'Nodophagy': New crossroads in Crohn disease pathogenesis.

Authors:  Mahendrasingh Ramjeet; Séamus Hussey; Dana J Philpott; Leonardo H Travassos
Journal:  Gut Microbes       Date:  2010-08-08

3.  Determination of the Relationship Between rs4986790 and rs4986791 Variants of TLR4 Gene and Lung Cancer.

Authors:  Hulyam Kurt; Cansu Ozbayer; Aysegul Bayramoglu; Hasan Veysi Gunes; İrfan Degirmenci; Kevser Setenay Oner; Muzaffer Metintas
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

4.  Association between receptor interacting serine/threonine kinase 2 polymorphisms and gastric cancer susceptibility.

Authors:  Masafumi Ota; Tomomitsu Tahara; Toshimi Otsuka; Wu Jing; Tomoe Nomura; Ranji Hayashi; Takeo Shimasaki; Masakatsu Nakamura; Tomoyuki Shibata; Tomiyasu Arisawa
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

Review 5.  Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?

Authors:  Li Yu; Liantang Wang; Shangwu Chen
Journal:  Cell Mol Life Sci       Date:  2011-11-03       Impact factor: 9.261

6.  Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis.

Authors:  Tian-Hui Zou; Zhen-Hua Wang; Jing-Yuan Fang
Journal:  Tumour Biol       Date:  2013-04-17

Review 7.  The Yin and Yang of Toll-like receptors in cancer.

Authors:  J-P Pradere; D H Dapito; R F Schwabe
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

8.  Toll-Like Receptor 4 Wild Type Homozygozity of Polymorphisms +896 and +1196 Is Associated with High Gastrin Serum Levels and Peptic Ulcer Risk.

Authors:  Vesa-Matti Pohjanen; Olli-Pekka Koivurova; Heikki Huhta; Olli Helminen; Johanna M Mäkinen; Jari M Karhukorpi; Tapio Joensuu; Pentti O Koistinen; Jarno M Valtonen; Seppo E Niemelä; Riitta A Karttunen; Tuomo J Karttunen
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

9.  The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: a case-control study and meta-analysis.

Authors:  Natalia Castaño-Rodríguez; Nadeem O Kaakoush; Khean-Lee Goh; Kwong Ming Fock; Hazel M Mitchell
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  NOD2 polymorphisms associated with cancer risk: a meta-analysis.

Authors:  Jingwei Liu; Caiyun He; Qian Xu; Chengzhong Xing; Yuan Yuan
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.